title: Willingness of pregnant women to vaccinate themselves and their newborns with the HPV vaccine.
abstract: OBJECTIVE
  To evaluate the willingness of pregnant women to accept the HPV vaccine for their newborns as well as themselves.
  
  
  METHODS
  An 18-item questionnaire was distributed to antepartum women. Demographic data about the respondent's current pregnancy and her knowledge of HPV and the HPV vaccine was collected. Information about the respondent's HPV and HPV vaccine status as well as her acceptance of the vaccine for herself during pregnancy and her newborn son and/or daughter after delivery was also collected.
  
  
  RESULTS
  Three hundred surveys were completed and available for review. Only 6 respondents (2%) had received the HPV vaccine. Despite the small group of patients who had previously been vaccinated, 112 respondents (37.3%) stated that they would receive the HPV vaccine during pregnancy if recommended by an obstetrician. 99 respondents (33%) stated that they would vaccinate their newborn female infant and 83 (27.7%) stated would vaccinate their male infants.
  
  
  CONCLUSIONS
  Providing the HPV vaccine to pregnant women as well as newborns could be an important way to increase the patient population who is protected against HPV. A percentage of pregnant women are willing to accept the vaccine for themselves and their newborns.
authors.affiliation: Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY 10021, United States.
authors.forename: Katherine P
authors.initials: KP
authors.lastname: Heyman
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Worley
authors.forename: Melissa K
authors.initials: MK
authors.lastname: Frey
authors.forename: Robin T
authors.initials: RT
authors.lastname: Kessler
authors.forename: Diane C
authors.initials: DC
authors.lastname: Bodurka
authors.forename: Brian M
authors.initials: BM
authors.lastname: Slomovitz
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control* / Q000821:virology; D011795:Surveys and Questionnaires; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination / Q000592:standards; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines